[go: up one dir, main page]

ES2099344T3 - Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina. - Google Patents

Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.

Info

Publication number
ES2099344T3
ES2099344T3 ES93117472T ES93117472T ES2099344T3 ES 2099344 T3 ES2099344 T3 ES 2099344T3 ES 93117472 T ES93117472 T ES 93117472T ES 93117472 T ES93117472 T ES 93117472T ES 2099344 T3 ES2099344 T3 ES 2099344T3
Authority
ES
Spain
Prior art keywords
morphine
flupirtin
combination preparation
pain treatment
based combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93117472T
Other languages
English (en)
Inventor
Bernd Dr Nickel
Michael Dr Lobisch
Stefan Prof Dr Szelenyi
Jurgen Prof Dr Engel
Peter Dr Emig
Gabriela Dr Pergande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2099344T3 publication Critical patent/ES2099344T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA COMBINACION A PARTIR DE FLUPIRTINA Y MORFINA TIENE LA PROPIEDAD DE UNA ACTUACION FUERTE ANALGESICA Y NINGUNA DEPENDENCIA DEL TIPO DE MORFINA ASI COMO SU TOLERANCIA. SE DESCRIBEN NUEVOS MEDICAMENTOS CON ESTA COMBINACION DE SUSTANCIA ACTIVA.
ES93117472T 1992-10-30 1993-10-28 Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina. Expired - Lifetime ES2099344T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4236752A DE4236752A1 (de) 1992-10-30 1992-10-30 Kombinationspräparat aus Flupirtin und Morphin zur Behandlung von Schmerzen und zur Vermeidung der Morphin-Abhängigkeit

Publications (1)

Publication Number Publication Date
ES2099344T3 true ES2099344T3 (es) 1997-05-16

Family

ID=6471783

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93117472T Expired - Lifetime ES2099344T3 (es) 1992-10-30 1993-10-28 Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.

Country Status (11)

Country Link
US (1) US5521178A (es)
EP (1) EP0595311B1 (es)
JP (1) JP3665354B2 (es)
AT (1) ATE147979T1 (es)
BR (1) BR9304431A (es)
CA (1) CA2102072C (es)
DE (2) DE4236752A1 (es)
DK (1) DK0595311T3 (es)
ES (1) ES2099344T3 (es)
GR (1) GR3022995T3 (es)
HU (1) HU219907B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
KR100354702B1 (ko) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
JP2003530308A (ja) * 1999-08-03 2003-10-14 アーヴェーデー．ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 犬および猫の退行性関節疾患に起因する痛みを軽減するためのフルピルチンの使用
CN1917876A (zh) * 2003-12-16 2007-02-21 Cns生物有限公司 方法和组合物
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
US20060052370A1 (en) * 2004-08-24 2006-03-09 Meyerson Laurence R Methods and compositions for treating nociceptive pain
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1688141A1 (en) 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
BRPI0607017B8 (pt) 2005-04-06 2021-05-25 Adamas Pharmaceuticals Inc composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
WO2006111830A2 (en) * 2005-04-20 2006-10-26 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
PL2097469T3 (pl) * 2006-11-28 2013-11-29 Purac Biochem Bv Stabilne cząstki laktydu
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
WO2010085848A1 (en) * 2009-01-30 2010-08-05 Relevare Aust. Pty Ltd Drug abuse deterrent, methods and compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI855016L (fi) * 1985-06-28 1986-12-29 Degussa Synergistisk kombination av flupirtin och 4-acetamido-fenol.

Also Published As

Publication number Publication date
CA2102072C (en) 2005-01-04
CA2102072A1 (en) 1994-05-01
EP0595311B1 (de) 1997-01-22
HUT66085A (en) 1994-09-28
JP3665354B2 (ja) 2005-06-29
DK0595311T3 (da) 1997-05-26
DE4236752A1 (de) 1994-05-05
HU9303089D0 (en) 1994-01-28
EP0595311A1 (de) 1994-05-04
JPH06211663A (ja) 1994-08-02
GR3022995T3 (en) 1997-07-30
HU219907B (hu) 2001-09-28
US5521178A (en) 1996-05-28
BR9304431A (pt) 1994-06-07
DE59305236D1 (de) 1997-03-06
ATE147979T1 (de) 1997-02-15

Similar Documents

Publication Publication Date Title
ES2099344T3 (es) Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
ATE210983T1 (de) Stabilisiertes kombinationsarzneimittel enthaltend naloxone und ein opiatanalgetikum
MX9206577A (es) COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
NL194360B (nl) Toedieningsinrichting en combinatie van een toedieningsinrichting en een huis voor houders van de toe te dienen substantie.
ATE63813T1 (de) Pharmazeutische zusammensetzungen von dihydrocodeine/ibuprofen und verfahren.
DE69421689D1 (de) Vorrichtung zur in-line verabreichung von drogen
DK1032376T3 (da) Anvendelse af benzhydrylsulfinylderivater til behandling af søvnighed af medicinal oprindelse
HUT53521A (en) Process for producing pharmaceutical compositions comprising morphine
ES2085337T3 (es) Comprimidos farmaceuticos.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
DK0583421T3 (da) Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
EP0357030A3 (en) Use of thromboxane a2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
DE60016460D1 (de) Verwendungen und zusammenstellungen von nitratestern als sedativa
DE3765243D1 (de) Ibuprofen und codein enthaltende, stabile, feste arzneimittel.
EP0781561A4 (en) NEW MEDICAL USE OF A 5HT 3 ANTAGONIST?
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
FR2582309B1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
BR9913072A (pt) Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia
EP0227531A3 (en) Pyroglutamic acid esters used as dermal penetration enhancers for drugs
DE69830114D1 (de) Analgetische Zusammensetzung welche Moxonidine und ein Opioid-Analgetika enthält
DE3788338D1 (de) Vorbehandlungswirkstoff zur perkutanen verabreichung.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
ATE106732T1 (de) Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung.
ATE247983T1 (de) Konjugate von einem interleukin-2 rezeptor spezifisch erkennenden faktor mit ribonuklease
ES2038722T3 (es) Procedimiento para preparar antagonistas de leucotrieno.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 595311

Country of ref document: ES